RG
Redmile Group’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
3,391,455
-249,379
| -7% | -$104K | 0.15% | 45 |
|
|
2025
Q1 | $2.27M | Sell |
3,640,834
-48,777
| -1% | -$30.4K | 0.21% | 49 |
|
|
2024
Q4 | $6.16M | Sell |
3,689,611
-146,965
| -4% | -$245K | 0.43% | 42 |
|
|
2024
Q3 | $6.98M | Sell |
3,836,576
-199,875
| -5% | -$364K | 0.41% | 41 |
|
|
2024
Q2 | $24.3M | Sell |
4,036,451
-290,058
| -7% | -$1.75M | 1.47% | 28 |
|
|
2024
Q1 | $48.2M | Buy |
4,326,509
+667,245
| +18% | +$7.44M | 1.77% | 18 |
|
|
2023
Q4 | $54.5M | Buy |
3,659,264
+2,375,975
| +185% | +$35.4M | 1.95% | 13 |
|
|
2023
Q3 | $6.16M | Hold |
1,283,289
| – | – | 0.29% | 51 |
|
|
2023
Q2 | $9.64M | Buy |
1,283,289
+696,312
| +119% | +$5.23M | 0.37% | 50 |
|
|
2023
Q1 | $2.65M | Sell |
586,977
-20,493
| -3% | -$92.6K | 0.12% | 64 |
|
|
2022
Q4 | $6.85M | Sell |
607,470
-144,627
| -19% | -$1.63M | 0.28% | 50 |
|
|
2022
Q3 | $7.2M | Sell |
752,097
-14,700
| -2% | -$141K | 0.28% | 55 |
|
|
2022
Q2 | $6.2M | Sell |
766,797
-5,600
| -0.7% | -$45.3K | 0.24% | 57 |
|
|
2022
Q1 | $13.1M | Sell |
772,397
-9,700
| -1% | -$164K | 0.41% | 50 |
|
|
2021
Q4 | $16.8M | Sell |
782,097
-82,338
| -10% | -$1.77M | 0.38% | 49 |
|
|
2021
Q3 | $63.8M | Sell |
864,435
-49,600
| -5% | -$3.66M | 1.11% | 29 |
|
|
2021
Q2 | $50M | Sell |
914,035
-64,565
| -7% | -$3.53M | 0.74% | 41 |
|
|
2021
Q1 | $72.2M | Buy |
978,600
+18,200
| +2% | +$1.34M | 1.02% | 36 |
|
|
2020
Q4 | $82.8M | Buy |
960,400
+553,000
| +136% | +$47.7M | 1% | 33 |
|
|
2020
Q3 | $15.4M | Buy |
+407,400
| New | +$15.4M | 0.28% | 59 |
|